Research Progress on the Occurrence and Therapeutic Mechanism of Ferroptosis in NSCLC
Overview
Authors
Affiliations
Ferroptosis refers to a novel way of cell death, inconsistent with the conventional concept of apoptosis and necrosis. It shows a close association with iron metabolism and oxidative damage, as marked by the significant increase of reactive oxygen species, the decreases of mitochondrial volume, and the thickening of membrane density. Recent studies confirmed that ferroptosis is closely associated with the occurrence, development, and therapy of the tumors. As impacted by the high levels of reactive oxygen species and lipid peroxides in lung cancer tissues, it is suggested that ferroptosis is more likely to occur in lung cancer tissues, which may act as a novel approach for non-small cell lung cancer (NSCLC) therapy. In the present study, the research achievements in recent years on the regulating mechanism of ferroptosis and its effect on the occurrence and the therapy of lung cancer are reviewed.
NUP155 and NDC1 interaction in NSCLC: a promising target for tumor progression.
Li K, Meng L, Yang Z, Hu W Front Pharmacol. 2024; 15:1514367.
PMID: 39720592 PMC: 11666513. DOI: 10.3389/fphar.2024.1514367.
Wang H, Liu H, Tang X, Lu G, Luo S, Du M Int J Cancer. 2024; 156(4):744-755.
PMID: 39319523 PMC: 11661923. DOI: 10.1002/ijc.35197.
Wen M, Zheng H, Zhao Y, Xia P Tob Induc Dis. 2024; 22.
PMID: 38947555 PMC: 11214278. DOI: 10.18332/tid/189490.
Zhang Q, Xia Y, Wang F, Yang D, Liang Z Front Pharmacol. 2024; 15:1385565.
PMID: 38751790 PMC: 11094314. DOI: 10.3389/fphar.2024.1385565.
Qin W, Wang P, Ding C, Peng F J Med Biochem. 2023; 42(4):607-615.
PMID: 38084245 PMC: 10710819. DOI: 10.5937/jomb0-39798.